Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Keyword
-
- Science & Technology (14)
- Life Sciences & Biomedicine (13)
- Hematology (5)
- Health Care Sciences & Services (4)
- Oncology (3)
-
- WARFARIN (3)
- ADMINISTRATIVE DATA (2)
- ATRIAL-FIBRILLATION (2)
- BREAST-CANCER (2)
- CLL (2)
- Cardiovascular System & Cardiology (2)
- DISEASE (2)
- Health disparity (2)
- Humans (2)
- IMPACT (2)
- MANAGEMENT (2)
- Mortality (2)
- RACIAL-DIFFERENCES (2)
- REPRODUCTIVE CONCERNS (2)
- RIVAROXABAN (2)
- Social Sciences (2)
- THERAPY (2)
- *Alleles;; Arthritis (1)
- 80 and over;; Antineoplastic Combined Chemotherapy Protocols/administration &;; dosage/*therapeutic use;; Carcinoma (1)
- ;; Biomedical (1)
- ACUTE MYOCARDIAL-INFARCTION (1)
- ADOLESCENT (1)
- ADOLESCENT CANCER (1)
- ADULTS (1)
- ASIAN-AMERICANS (1)
Articles 1 - 30 of 179
Full-Text Articles in Internal Medicine
Rationale And Design For The Study Of Rivaroxaban To Reduce Thrombotic Events, Hospitalization And Death In Outpatients With Covid-19: The Prevent-Hd Study, W. H. Capell, E. S. Barnathan, G. Piazza, A. C. Spyropoulos, J. Hsia, S. Bull, C. Lipardi, C. Sugarmann, E. Suh, M. P. Bonaca, +2 Additional Authors
Rationale And Design For The Study Of Rivaroxaban To Reduce Thrombotic Events, Hospitalization And Death In Outpatients With Covid-19: The Prevent-Hd Study, W. H. Capell, E. S. Barnathan, G. Piazza, A. C. Spyropoulos, J. Hsia, S. Bull, C. Lipardi, C. Sugarmann, E. Suh, M. P. Bonaca, +2 Additional Authors
Journal Articles
© 2021 Elsevier Inc. Background: COVID-19 is associated with both venous and arterial thrombotic complications. While prophylactic anticoagulation is now widely recommended for hospitalized patients with COVID-19, the effectiveness and safety of thromboprophylaxis in outpatients with COVID-19 has not been established. Study Design: PREVENT-HD is a double-blind, placebo-controlled, pragmatic, event-driven phase 3 trial to evaluate the efficacy and safety of rivaroxaban in symptomatic outpatients with laboratory-confirmed COVID-19 at risk for thrombotic events, hospitalization, and death. Several challenges posed by the pandemic have necessitated innovative approaches to clinical trial design, start-up, and conduct. Participants are randomized in a 1:1 ratio, stratified …
Convalescent Plasma For Covid-19 Complicated By Ards Due To Trali, K. Y. Wang, P. Shah, M. Pierce
Convalescent Plasma For Covid-19 Complicated By Ards Due To Trali, K. Y. Wang, P. Shah, M. Pierce
Journal Articles
© 2021 BMJ Publishing Group. All rights reserved. Convalescent plasma, which contains antibodies from recovered individuals, has been used as an effective treatment for infectious diseases in the past and is currently being used as a potential treatment option for COVID-19. Multiple studies have reported this treatment to be safe. We report a case of a patient who developed acute respiratory distress syndrome (ARDS) with features suggestive of transfusion-related acute lung injury after being treated with convalescent plasma for COVID-19. We emphasise the need to be aware of the potential risk of transfusion reactions and disease worsening with convalescent plasma …
Ethnic Differences In Thromboprophylaxis For Covid-19 Patients: Should They Be Considered?, T. Iba, J. M. Connors, A. C. Spyropoulos, H. Wada, J. H. Levy
Ethnic Differences In Thromboprophylaxis For Covid-19 Patients: Should They Be Considered?, T. Iba, J. M. Connors, A. C. Spyropoulos, H. Wada, J. H. Levy
Journal Articles
© 2021, Japanese Society of Hematology. Thromboembolic events contribute to morbidity and mortality in coronavirus disease 2019 (COVID-19). As a result, thromboprophylaxis using low-molecular-weight heparin (LMWH) is universally recommended for hospitalized patients based on multiple guidelines. However, ethnic differences with respect to thrombogenicity have been reported and the incidence of thromboembolic events is considered to be lower in the Asian population. Despite the importance of thromboprophylaxis, bleeding is also a side effect that should be considered. We examine the data relating to potential ethnic differences in thrombosis and bleeding in COVID-19. Although sufficient data is not yet available, current evidence …
Famotidine Use Is Associated With Improved Clinical Outcomes In Hospitalized Covid-19 Patients: A Propensity Score Matched Retrospective Cohort Study., D. E. Freedberg, J. Conigliaro, T. C. Wang, K. J. Tracey, M. V. Callahan, J. A. Abrams, Famotidine Research Group Famotidine Research Grou, M. E. Sobieszczyk, D. D. Markowitz, A. Gupta, M. R. O'Donnell, J. Li, D. A. Tuveson, Z. Jin, W. C. Turner, D. W. Landry
Famotidine Use Is Associated With Improved Clinical Outcomes In Hospitalized Covid-19 Patients: A Propensity Score Matched Retrospective Cohort Study., D. E. Freedberg, J. Conigliaro, T. C. Wang, K. J. Tracey, M. V. Callahan, J. A. Abrams, Famotidine Research Group Famotidine Research Grou, M. E. Sobieszczyk, D. D. Markowitz, A. Gupta, M. R. O'Donnell, J. Li, D. A. Tuveson, Z. Jin, W. C. Turner, D. W. Landry
Journal Articles
No abstract provided.
The Uses Of Overnight Pulse Oximetry, S. Singh, S. Khan, D. Singh, S. Verma, A. Talwar
The Uses Of Overnight Pulse Oximetry, S. Singh, S. Khan, D. Singh, S. Verma, A. Talwar
Journal Articles
© 2020 Indian Chest Society Published by Wolters Kluwer - Medknow. Overnight pulse oximetry (OPO) has proven to be an effective and beneficial technique to determine the cardiorespiratory status of patients in both the inpatient and outpatient settings. It is a cheap, safe, reliable, simple, and accurate method of patient monitoring as compared to the expensive and labor-intensive method of multichannel polysomnography for detecting sleep-disordered breathing. It provides accurate information about patient's oxygenation status and also helps in monitoring the response to continuous positive airway pressure and in the surgical treatment of obstructive sleep apnea (OSA). Nocturnal hypoxemia portends a …
Covid-19: Magnifying The Effect Of Health Disparities, E. J. Kim, L. Marrast, J. Conigliaro
Covid-19: Magnifying The Effect Of Health Disparities, E. J. Kim, L. Marrast, J. Conigliaro
Journal Articles
No abstract provided.
Obstructive Lung Disease Secondary To Compression Of The Bronchus By An Enlarged Pulmonary Artery, J. Panthappattu, V. Sharma, S. Verma, A. Talwar
Obstructive Lung Disease Secondary To Compression Of The Bronchus By An Enlarged Pulmonary Artery, J. Panthappattu, V. Sharma, S. Verma, A. Talwar
Journal Articles
© 2020 Indian Chest Society Published by Wolters Kluwer - Medknow. In clinical practice, the presence of wheezing generally indicates an airway disease. In rare circumstances, adjacent mediastinal structures may compress the tracheobronchial tree leading to obstructive physiology. Compression of the tracheobronchial region by an enlarged pulmonary artery (PA) is exceedingly rare. We present here a case of pulmonary hypertension, where the enlarged PA resulted in obstructive lung physiology with a relevant review of the literature.
A Case Of Plasmodium Falciparum Malaria With A Prolonged Incubation Period Of Four Years., E. Sleiman, A. Upadhyaya, A. Glaser, M. Krzyzak
A Case Of Plasmodium Falciparum Malaria With A Prolonged Incubation Period Of Four Years., E. Sleiman, A. Upadhyaya, A. Glaser, M. Krzyzak
Journal Articles
With increased global travel, unique diseases from different parts of the world pose a new category of differential diagnosis, and an incubation period of different infectious diseases helps narrow differential diagnosis to point to one specific etiology. The normal incubation period of Plasmodium falciparum malariais 7-40 days. We report a case of symptomatic P. falciparum malaria that manifested four years after a visit to a malaria-endemic area in a 51-year-old female patient. Our case illustrates the importance of a broad differential with regard to infectious disease including remote travel history and raises questions of the survival of P. falciparum for …
External Validation Of A Venous Thromboembolic Risk Score For Cancer Outpatients With Solid Tumors: The Compass-Cat Venous Thromboembolism Risk Assessment Model, A. C. Spyropoulos, J. B. Eldredge, L. N. Anand, M. Zhang, M. Qiu, S. Nourabadi, D. J. Rosenberg
External Validation Of A Venous Thromboembolic Risk Score For Cancer Outpatients With Solid Tumors: The Compass-Cat Venous Thromboembolism Risk Assessment Model, A. C. Spyropoulos, J. B. Eldredge, L. N. Anand, M. Zhang, M. Qiu, S. Nourabadi, D. J. Rosenberg
Journal Articles
No abstract provided.
Hospital-Based Use Of Thromboprophylaxis In Patients With Covid-19, A. C. Spyropoulos, W. Ageno, E. S. Barnathan
Hospital-Based Use Of Thromboprophylaxis In Patients With Covid-19, A. C. Spyropoulos, W. Ageno, E. S. Barnathan
Journal Articles
No abstract provided.
Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal And Major Thromboembolic Events In Medically Ill Patients, A. C. Spyropoulos, W. Ageno, G. W. Albers, C. G. Elliott, J. L. Halperin, W. R. Hiatt, G. A. Maynard, P. G. Steg, J. I. Weitz, G. E. Raskob, +3 Additional Authors
Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal And Major Thromboembolic Events In Medically Ill Patients, A. C. Spyropoulos, W. Ageno, G. W. Albers, C. G. Elliott, J. L. Halperin, W. R. Hiatt, G. A. Maynard, P. G. Steg, J. I. Weitz, G. E. Raskob, +3 Additional Authors
Journal Articles
© 2020 The Authors Background: Hospitalized acutely ill medical patients are at risk for fatal and major thromboembolic events. Whether use of extended-duration primary thromboprophylaxis can prevent such events is unknown. Objectives: The purpose of this study was to evaluate whether extended-duration rivaroxaban reduces the risk of venous and arterial fatal and major thromboembolic events without significantly increasing major bleeding in acutely ill medical patients after discharge. Methods: MARINER (A Study of Rivaroxaban [JNJ-39039039] on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients) studied acutely ill medical patients with additional risk factors for venous thromboembolism (VTE). Medically ill patients with …
Decreasing The Peril Of Antimicrobial Resistance Through Enhanced Health Literacy In Outpatient Settings: An Underrecognized Approach To Advance Antimicrobial Stewardship, E. D. Hermsen, E. L. Macgeorge, M. L. Andresen, L. M. Myers, C. J. Lillis, B. M. Rosof
Decreasing The Peril Of Antimicrobial Resistance Through Enhanced Health Literacy In Outpatient Settings: An Underrecognized Approach To Advance Antimicrobial Stewardship, E. D. Hermsen, E. L. Macgeorge, M. L. Andresen, L. M. Myers, C. J. Lillis, B. M. Rosof
Journal Articles
© 2020, The Author(s). Globally, antimicrobial resistance (AMR) is a serious problem causing 700,000 deaths annually. By 2050, AMR is expected to cause approximately 10 million deaths globally each year if allowed to increase at the present rate. Many individuals have limited knowledge regarding appropriate antibiotic use and AMR. Most antibiotic use occurs in the outpatient setting, with approximately 30% of antibiotics prescribed deemed unnecessary. Antimicrobial stewardship (AMS) is a means to reduce inappropriate antibiotic use and AMR. While existing AMS efforts generally focus on the inpatient setting, a significant gap is present in the outpatient setting. A common theme …
The Covid-19 Pandemic: Experiences Of A Geriatrician-Hospitalist Caring For Older Adults, L Sinvani
The Covid-19 Pandemic: Experiences Of A Geriatrician-Hospitalist Caring For Older Adults, L Sinvani
Journal Articles
No abstract provided.
Emergence Of Institutional Antithrombotic Protocols For Coronavirus 2019., Kp Cohoon, G Mahé, Aj Tafur, Ac Spyropoulos
Emergence Of Institutional Antithrombotic Protocols For Coronavirus 2019., Kp Cohoon, G Mahé, Aj Tafur, Ac Spyropoulos
Journal Articles
No abstract provided.
The Renin–Angiotensin System: An Integrated View Of Lung Disease And Coagulopathy In Covid-19 And Therapeutic Implications, B Diamond
Journal Articles
No abstract provided.
Introduction To The Special Series: Translating Behavioral Medicine Research To Prevent And Control The Spread Of Covid-19., A. M. Delamater, S. M. Miller, D. J. Bowen, M. A. Diefenbach, K. P. Tercyak
Introduction To The Special Series: Translating Behavioral Medicine Research To Prevent And Control The Spread Of Covid-19., A. M. Delamater, S. M. Miller, D. J. Bowen, M. A. Diefenbach, K. P. Tercyak
Journal Articles
No abstract provided.
The Management Of Venous Thromboembolism In Hospitalized Patients With Covid-19, A. C. Spyropoulos
The Management Of Venous Thromboembolism In Hospitalized Patients With Covid-19, A. C. Spyropoulos
Journal Articles
No abstract provided.
Unique Case Of Central Retinal Artery Occlusion Secondary To Covid-19 Disease, S. Acharya, M. Diamond, S. Anwar, A. Glaser, P. Tyagi
Unique Case Of Central Retinal Artery Occlusion Secondary To Covid-19 Disease, S. Acharya, M. Diamond, S. Anwar, A. Glaser, P. Tyagi
Journal Articles
© 2020 The Authors SARS-COVID-2 has been noted to be associated with neurological symptoms and complications including stroke. Hypercoagulability associated with COVID-19 has been described as a “sepsis-induced coagulopathy” and may predispose to spectrum of thromboembolic events. We present a unique article of isolated central retinal artery occlusion secondary to SARS-COV 2.
Ensuring Editorial Continuity And Quality Of Science During The Covid-19 Storm: The Icm Experience, T. Bein, A. Vargiolu, G. Citerio, S. Jaber, M. Schetz, A. Aneman, Y. Arabi, K. Brown, P. Mayo, M. Shankar-Hari, +11 Additional Authors
Ensuring Editorial Continuity And Quality Of Science During The Covid-19 Storm: The Icm Experience, T. Bein, A. Vargiolu, G. Citerio, S. Jaber, M. Schetz, A. Aneman, Y. Arabi, K. Brown, P. Mayo, M. Shankar-Hari, +11 Additional Authors
Journal Articles
No abstract provided.
Risk Models For Vte And Bleeding In Medical Inpatients: Systematic Identification And Expert Assessment, A. J. Darzi, S. G. Karam, F. A. Spencer, A. C. Spyropoulos, L. Mbuagbaw, S. C. Woller, N. A. Zakai, M. B. Streiff, M. K. Gould, H. J. Schunemann, +9 Additional Authors
Risk Models For Vte And Bleeding In Medical Inpatients: Systematic Identification And Expert Assessment, A. J. Darzi, S. G. Karam, F. A. Spencer, A. C. Spyropoulos, L. Mbuagbaw, S. C. Woller, N. A. Zakai, M. B. Streiff, M. K. Gould, H. J. Schunemann, +9 Additional Authors
Journal Articles
No abstract provided.
Predictors Of Preprocedural Direct Oral Anticoagulant Levels In Patients Having An Elective Surgery Or Procedure, J. R. Shaw, N. Li, T. Vanassche, M. Coppens, A. C. Spyropoulos, S. Syed, M. Radwi, J. Duncan, S. Schulman, J. D. Douketis
Predictors Of Preprocedural Direct Oral Anticoagulant Levels In Patients Having An Elective Surgery Or Procedure, J. R. Shaw, N. Li, T. Vanassche, M. Coppens, A. C. Spyropoulos, S. Syed, M. Radwi, J. Duncan, S. Schulman, J. D. Douketis
Journal Articles
No abstract provided.
Impact Of Idelalisib On Health-Related Quality Of Life In Patients With Relapsed Chronic Lymphocytic Leukemia In A Phase Iii Randomized Trial, P. Ghia, S. E. Coutre, B. D. Cheson, J. C. Barrientos, P. Hillmen, A. R. Pettitt, A. D. Zelenetz, S. Shreay, M. Hallek, R. R. Furman
Impact Of Idelalisib On Health-Related Quality Of Life In Patients With Relapsed Chronic Lymphocytic Leukemia In A Phase Iii Randomized Trial, P. Ghia, S. E. Coutre, B. D. Cheson, J. C. Barrientos, P. Hillmen, A. R. Pettitt, A. D. Zelenetz, S. Shreay, M. Hallek, R. R. Furman
Journal Articles
No abstract provided.
Case And Commentary: How Should Clinicians' Performance Be Assessed When Health Care Organizations Implement Behavioral Architecture That Generates Negative Consequences?, S. Richardson
Journal Articles
© 2020 American Medical Association. All rights reserved. Behavioral interventions have been shown to have powerful effects on human behavior both outside of and within the context of health care. As organizations increasingly adopt behavioral architecture, care must be taken to consider its potential negative consequences. An evidencedbased approach is best, whereby interventions that might have a significant deleterious effect on patients' health outcomes are first tested and rigorously evaluated before being systematically rolled out. In the case of clinical decision support, brief and thorough instructions should be provided for use. Physician performance when using these systems is best measured …
Anticoagulant Reversal Strategies In The Emergency Department Setting: Recommendations Of A Multidisciplinary Expert Panel, C. W. Baugh, M. Levine, D. Cornutt, J. W. Wilson, R. Kwun, C. E. Mahan, C. V. Pollack, E. G. Marcolini, A. C. Spyropoulos, J. Williams
Anticoagulant Reversal Strategies In The Emergency Department Setting: Recommendations Of A Multidisciplinary Expert Panel, C. W. Baugh, M. Levine, D. Cornutt, J. W. Wilson, R. Kwun, C. E. Mahan, C. V. Pollack, E. G. Marcolini, A. C. Spyropoulos, J. Williams
Journal Articles
No abstract provided.
Utility Of D-Dimer In Predicting Venous Thromboembolism In Non-Mechanically Ventilated Covid-19 Survivors., P. C. Nauka, S. W. Baron, A. Assa, L. Mohrmann, S. Jindal, E. Oran, G. Glazman-Kuczaj, W. N. Southern, S. Chekuri
Utility Of D-Dimer In Predicting Venous Thromboembolism In Non-Mechanically Ventilated Covid-19 Survivors., P. C. Nauka, S. W. Baron, A. Assa, L. Mohrmann, S. Jindal, E. Oran, G. Glazman-Kuczaj, W. N. Southern, S. Chekuri
Journal Articles
No abstract provided.
An Approach To Predicting Patient Experience Through Machine Learning And Social Network Analysis., V. Bari, J. S. Hirsch, J. Narvaez, R. Sardinia, K. R. Bock, M. I. Oppenheim, M. Meytlis
An Approach To Predicting Patient Experience Through Machine Learning And Social Network Analysis., V. Bari, J. S. Hirsch, J. Narvaez, R. Sardinia, K. R. Bock, M. I. Oppenheim, M. Meytlis
Journal Articles
OBJECTIVE:Improving the patient experience has become an essential component of any healthcare system's performance metrics portfolio. In this study, we developed a machine learning model to predict a patient's response to the Hospital Consumer Assessment of Healthcare Providers and Systems survey's "Doctor Communications" domain questions while simultaneously identifying most impactful providers in a network. MATERIALS AND METHODS:This is an observational study of patients admitted to a single tertiary care hospital between 2016 and 2020. Using machine learning algorithms, electronic health record data were used to predict patient responses to Hospital Consumer Assessment of Healthcare Providers and Systems survey questions in …
Covid-19 And Thrombotic Or Thromboembolic Disease: Implications For Prevention, Antithrombotic Therapy, And Follow-Up: Jacc State-Of-The-Art Review, B. Bikdeli, M. V. Madhavan, D. Jimenez, T. Chuich, I. Dreyfus, E. Driggin, C. D. Nigoghossian, W. Ageno, A. C. Spyropoulos, G. Y. Lip, +10 Additional Authors
Covid-19 And Thrombotic Or Thromboembolic Disease: Implications For Prevention, Antithrombotic Therapy, And Follow-Up: Jacc State-Of-The-Art Review, B. Bikdeli, M. V. Madhavan, D. Jimenez, T. Chuich, I. Dreyfus, E. Driggin, C. D. Nigoghossian, W. Ageno, A. C. Spyropoulos, G. Y. Lip, +10 Additional Authors
Journal Articles
© 2020 American College of Cardiology Foundation Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients to thrombotic disease, both in the venous and arterial circulations, because of excessive inflammation, platelet activation, endothelial dysfunction, and stasis. In addition, many patients receiving antithrombotic therapy for thrombotic disease may develop COVID-19, which can have implications for choice, dosing, and laboratory monitoring of antithrombotic therapy. Moreover, during a time with much focus on COVID-19, it is critical to consider how to optimize the available technology to care for patients without COVID-19 who have thrombotic …
Famotidine Use And Quantitative Symptom Tracking For Covid-19 In Non-Hospitalised Patients: A Case Series., T Janowitz, E Gablenz, D Pattinson, Tc Wang, J Conigliaro, K Tracey, D Tuveson
Famotidine Use And Quantitative Symptom Tracking For Covid-19 In Non-Hospitalised Patients: A Case Series., T Janowitz, E Gablenz, D Pattinson, Tc Wang, J Conigliaro, K Tracey, D Tuveson
Journal Articles
No abstract provided.
The Underrecognized Prothrombotic Vascular Disease Of Covid-19., Kp Cohoon, G Mahé, Ac Spyropoulos
The Underrecognized Prothrombotic Vascular Disease Of Covid-19., Kp Cohoon, G Mahé, Ac Spyropoulos
Journal Articles
No abstract provided.
Acute Limb Ischemia In Covid-19 Disease: A Mysterious Coagulopathy., S. Anwar, S. Acharya, S. Shabih, A. Khabut
Acute Limb Ischemia In Covid-19 Disease: A Mysterious Coagulopathy., S. Anwar, S. Acharya, S. Shabih, A. Khabut
Journal Articles
Severe coronavirus disease 2019 (COVID-19) as a respiratory tract infection has been noted to be a causative agent for acute respiratory distress syndrome, shock, and multiple organ failure. It is also being suggested that COVID-19 results in serious systemic coagulopathies similar to disseminated intravascular coagulation. We describe a case of severe arterial thrombosis induced by COVID-19 infection along with its pathological implications.